Government expands access to cancer therapy but holds short on pan-tumour listing

Chifumi Umeda, Managing Director, MSD Australia and New Zealand, said, "Separately, we are continuing our discussions with the government to support further access to KEYTRUDA through multi-cancer funding following the PBAC’s positive recommendation in December 2025." …